Waldeström macroglobulinaemia relapsing with focal bone disease and achieving major response with single-agent zoledronic acid

MeSH terms

• Antibodies, Monoclonal, Murine-Derived / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Bone Density Conservation Agents / administration & dosage
• Bone Density Conservation Agents / therapeutic use*
• Bone Resorption
• Boronic Acids / administration & dosage
• Bortezomib
• Combined Modality Therapy
• Dexamethasone / administration & dosage
• Diphosphonates / administration & dosage
• Diphosphonates / therapeutic use*
• Hematopoietic Stem Cell Transplantation
• Humans
• Imidazoles / administration & dosage
• Imidazoles / therapeutic use*
• Male
• Melphalan / administration & dosage
• Middle Aged
• Multimodal Imaging*
• Osteolysis / diagnostic imaging*
• Osteolysis / drug therapy
• Osteolysis / etiology
• Positron-Emission Tomography*
• Pyrazines / administration & dosage
• Recurrence
• Remission Induction
• Rituximab
• Tomography, X-Ray Computed*
• Waldenstrom Macroglobulinemia / complications
• Waldenstrom Macroglobulinemia / diagnostic imaging*
• Waldenstrom Macroglobulinemia / drug therapy
• Waldenstrom Macroglobulinemia / surgery
• Zoledronic Acid